Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-07-21ADPT144Harlan Robins plan to sell securities of Adaptive Biotechnologies Corporation under Form 144MEDIUM
Harlan Robins filed Form 144 to notify SEC of plan to sell 492400 units of Adaptive Biotechnologies Corporation securities around 2026-07-21, with aggregate market value of $11,118,392.00. The total outstanding units is 160044392.0. The amount planned to be sold represents 0.31% of total outstanding units; Recent trans...
Mid CapBiotechnology
2026-07-21DYAI144Francisco Trust under agreement dated February 28, 1996 plan to sell securities of Dyadic International Inc under Form 144MEDIUM
Francisco Trust under agreement dated February 28, 1996 filed Form 144 to notify SEC of plan to sell 364387 units of Dyadic International Inc securities around 2026-07-21, with aggregate market value of $539,295.72. The total outstanding units is 36438703.0. The amount planned to be sold represents 1.00% of total outst...
Nano CapBiotechnology
2026-07-21EYPT144Lurker Nancy plan to sell securities of EyePoint, Inc. under Form 144MEDIUM
Lurker Nancy filed Form 144 to notify SEC of plan to sell 421235 units of EyePoint, Inc. securities around 2026-07-21, with aggregate market value of $5,497,116.75. The total outstanding units is 83841298.0. The amount planned to be sold represents 0.50% of total outstanding units; ...
Small CapBiotechnology
2026-07-21DYADIC INTERNATIONAL INC144Francisco Trust under agreement dated February 28, 1996 plan to sell securities of Dyadic International Inc under Form 144DuplicateMEDIUM
Francisco Trust under agreement dated February 28, 1996 filed Form 144 to notify SEC of plan to sell 364387 units of Dyadic International Inc securities around 2026-07-21, with aggregate market value of $539,295.72. The total outstanding units is 36438703.0. The amount planned to be sold represents 1.00% of total outst...
Nano CapBiotechnology